Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Heart Disease, Ischemic

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Heart Disease, Ischemic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arheden, H; Carlsson, M; Hedström, E; Heiberg, E; Jovinge, S; Ubachs, JF1
Friedrich, MG1
Bernhardt, P; Budde, R; Kleinertz, K; Krämer, A; Leischik, R; Morell, R; Overhoff, U; Steffens, M; Strohm, O1
Bongartz, G; Bremerich, J; Buser, P; Grädel, C; Müller-Brand, J; Pfisterer, M; Steinbrich, W1

Other Studies

4 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Heart Disease, Ischemic

ArticleYear
Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography.
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:5

    Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Follow-Up Studies; Heart Ventricles; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Organometallic Compounds; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2009
A closer look on the battlefield: the salvaged area at risk as an outcome marker for myocardial reperfusion.
    JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:5

    Topics: Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Heart Ventricles; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Ischemia; Myocardium; Organometallic Compounds; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2009
Safety of adenosine stress magnetic resonance imaging using a mobile cardiac magnetic resonance system.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2006, Volume: 8, Issue:3

    Topics: Adenosine; Contrast Media; Feasibility Studies; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Mobile Health Units; Myocardial Ischemia; Organometallic Compounds; Prospective Studies; Safety

2006
Noninvasive stress testing of myocardial ischemia: comparison of GRE-MRI perfusion and wall motion analysis to 99 mTc-MIBI-SPECT, relation to coronary angiography.
    European radiology, 1997, Volume: 7, Issue:7

    Topics: Contrast Media; Coronary Angiography; Coronary Circulation; Dipyridamole; Electrocardiography; Feasibility Studies; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Organometallic Compounds; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents

1997